Pharmacokinetics of single‐dose rivaroxaban under fed state in obese vs. non‐obese subjects: An open‐label controlled clinical trial (RIVOBESE‐PK)

• Główni autorzy: Majdoleen Alalawneh (Autor), Ahmed Awaisu (Autor), Ibtihal Abdallah (Autor), Hazem Elewa (Autor), Mohammed Danjuma (Autor), Kamal M. Matar (Autor), Akram M. ElKashlan (Autor), Yasser Elshayep (Autor), Fathy Ibrahim (Autor), Ousama Rachid (Autor)
• Format: Książka
• Wydane: Wiley, 2024-06-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract The evidence of rivaroxaban's pharmacokinetics in obese compared with non‐obese populations remains inconclusive. We aimed to compare the pharmacokinetic profile of rivaroxaban between obese and non‐obese populations under fed state. Participants who met the study's eligibility cr...